Outcome

Itron and Duke Energy Florida Collaborate to Deliver Managed EV Charging Program

Retrieved on: 
Tuesday, March 22, 2022

The DER Optimizer solution is a suite of modules that enables utilities to monitor residential electric vehicle (EV) charging and manage holistic residential EV charging programs at scale.

Key Points: 
  • The DER Optimizer solution is a suite of modules that enables utilities to monitor residential electric vehicle (EV) charging and manage holistic residential EV charging programs at scale.
  • Duke Energy Florida will use its existing instance of IntelliSOURCE EnterpriseTM to deploy the new DER Optimization modules and run a new managed EV charging program.
  • During that time, Duke Energy Florida will use Itrons DER Optimizer to collect permissible EV charging session data in near-real time and gain insights into residential EV charging behavior.
  • As the first utility to deploy Itrons DER Optimizer solution, Duke Energy is leading the way to better manage EV charging for residential consumers in Florida.

Itron to Modernize Water Infrastructure in Tennessee

Retrieved on: 
Tuesday, March 15, 2022

Utilizing Temetra, CUD will automate meter reading collection across their water distribution system and provide a seamless billing experience for their customers.

Key Points: 
  • Utilizing Temetra, CUD will automate meter reading collection across their water distribution system and provide a seamless billing experience for their customers.
  • Itron looks forward to working with CUD to provide the insights and technology it needs to enhance operational efficiency and deliver reliable water service to customers.
  • As water utilities look to conserve water resources, Itron is committed to building out water operations management outcomes services, such as leak detection, to address a broader set of use cases on top of meter data collection.
  • Itron enables utilities and cities to safely, securely and reliably deliver critical infrastructure solutions to communities in more than 100 countries.

DeepIntent Expands Partnerships and Team to Lead Pharma's Dramatic CTV Advertising Shift

Retrieved on: 
Tuesday, March 8, 2022

CTV represents the future of programmatic advertising for pharmaceutical brands, which currently spend more than $4.5 billion on traditional television advertising annually.

Key Points: 
  • CTV represents the future of programmatic advertising for pharmaceutical brands, which currently spend more than $4.5 billion on traditional television advertising annually.
  • Nine of the top ten pharmaceutical companies use DeepIntent, and the company maintains a mix of exclusive and preferential partnerships with several leading publishers and CTV device makers.
  • Additionally, ad tech veteran Aaron Letscher joined DeepIntent as vice president of CTV partnerships following successful tours with Warner Media, DoubleClick, and Right Media/Yahoo.
  • "We've seen an acceleration in demand for CTV across our platform over the past year, marking a new frontier in healthcare advertising.

CareDx Announces Cibiltech Initiates CIBIL Study Using iBox Artificial Intelligence to Monitor Kidney Transplant Patients

Retrieved on: 
Thursday, March 3, 2022

We look forward to the results of both CIBIL and OKRA, and to making iBox more widely available to clinicians in the United States as an additional clinical tool.

Key Points: 
  • We look forward to the results of both CIBIL and OKRA, and to making iBox more widely available to clinicians in the United States as an additional clinical tool.
  • CareDx is a minority owner of Cibiltech and holds exclusive rights to commercialize iBox in the United States.
  • We are excited to initiate the CIBIL study to assess the clinical and health economic benefits of using the iBox AI algorithm as an early intervention monitoring tool for kidney transplant patients worldwide, said Stephane Tholander, CEO of Cibiltech.
  • CareDx expressly disclaims any obligation, except as required by law, or undertaking to update or revise any such forward-looking statements.

On a Mission to Improve Financial Access and Outcomes for All Americans, Atomic Secures $40 Million Series B Funding

Retrieved on: 
Thursday, March 3, 2022

On a Mission to Improve Financial Access and Outcomes for All Americans, Atomic Secures $40 Million Series B Funding

Key Points: 
  • On a Mission to Improve Financial Access and Outcomes for All Americans, Atomic Secures $40 Million Series B Funding
    Payroll represents a rich store of consumer data.
  • Making it accessible and interoperable has the potential to drive new, lower-cost financial products for customers, thereby improving their financial outcomes, while providing financial institutions with new tools to reduce fraud, improve privacy, and increase customer retention.
  • "Our vision of greater financial fairness for all is extremely compelling," said Scott Weinert, Co-founder and CTO of Atomic.
  • Atomic has raised $78.6 million from investors, including Mercato Partners Traverse, Greylock, Core Innovation Capital, Portage, and ATX Venture Partners.

Innovator ETFs Announces New Upside Caps for March Series of U.S. Equity Buffer ETFs

Retrieved on: 
Tuesday, March 1, 2022

Unlike structured notes, which offer limited liquidity, Innovator Defined Outcome ETFs trade throughout the day on an exchange, like a stock.

Key Points: 
  • Unlike structured notes, which offer limited liquidity, Innovator Defined Outcome ETFs trade throughout the day on an exchange, like a stock.
  • The outbreak of COVID-19 has negatively affected the worldwide economy, individual countries, individual companies and the market in general.
  • Consequently, ETFs usually generate fewer capital gain distributions overall, which can make them somewhat more tax-efficient than mutual funds.
  • 5 Defined Outcome ETFs are not backed by the faith and credit of an Issuing institution, so they are not exposed to credit risk.

New Credit Index Points to Lending Opportunities

Retrieved on: 
Tuesday, March 1, 2022

BALTIMORE, March 01, 2022 (GLOBE NEWSWIRE) -- CreditXpert, the predictive credit score platform that helps lenders expand homeownership opportunities, has launched a new mortgage credit score index.

Key Points: 
  • BALTIMORE, March 01, 2022 (GLOBE NEWSWIRE) -- CreditXpert, the predictive credit score platform that helps lenders expand homeownership opportunities, has launched a new mortgage credit score index.
  • The Mortgage Credit Potential Index (MCPI) is a monthly snapshot of mid-score mortgage credit inquiries by 20-point bands that serves as an indicator of changes in mortgage demand across the credit spectrum.
  • The MCPI will help lenders see how shifts in volume and applicant credit potential should shape their lending operations to reduce credit fallout in an increasingly competitive mortgage market.
  • CreditXpert is not a credit counseling, credit repair, or credit reporting agency.

Innovator ETFs Announces New Upside Cap Ranges for March Series of U.S. Equity Buffer ETFs

Retrieved on: 
Tuesday, February 22, 2022

Unlike structured notes, which offer limited liquidity, Innovator Defined Outcome ETFs trade throughout the day on an exchange, like a stock.

Key Points: 
  • Unlike structured notes, which offer limited liquidity, Innovator Defined Outcome ETFs trade throughout the day on an exchange, like a stock.
  • The outbreak of COVID-19 has negatively affected the worldwide economy, individual countries, individual companies and the market in general.
  • Consequently, ETFs usually generate fewer capital gain distributions overall, which can make them somewhat more tax-efficient than mutual funds.
  • 5 Defined Outcome ETFs are not backed by the faith and credit of an Issuing institution, so they are not exposed to credit risk.

New Data Presented at ISC 2022 Further Validates Impact of the Viz Platform for Intelligent Care Coordination in the Real World

Retrieved on: 
Friday, February 11, 2022

Data from several new studies presented this week at the American Heart Association International Stroke Conference (ISC) further validates the best-in-class sensitivity and specificity of Viz.ais intelligent care coordination platform for stroke in real world settings across multiple commercial modules.

Key Points: 
  • Data from several new studies presented this week at the American Heart Association International Stroke Conference (ISC) further validates the best-in-class sensitivity and specificity of Viz.ais intelligent care coordination platform for stroke in real world settings across multiple commercial modules.
  • Viz LVO is a promising AI-driven software that can reliably detect ICA-T and M1 LVOs with impressive NPV, sensitivity, and overall accuracy.
  • An additional abstract from the same center studied 682 patients analyzed with Viz ICH and found an overall accuracy of 99%.
  • Also in 2021, the FDA cleared the Viz PE and Viz Aortic modules, making the Viz Platform multi-disciplinary.

Itron Named a Visionary in the 2022 Gartner® Magic Quadrant™ for Managed IoT Connectivity Services, Worldwide

Retrieved on: 
Thursday, February 3, 2022

Itron, Inc. (NASDAQ: ITRI), which is transforming the way utilities and cities manage energy and water, announced that it has been named a Visionary in the 2022 Gartner Magic Quadrant for Managed IoT Connectivity Services, Worldwide1.

Key Points: 
  • Itron, Inc. (NASDAQ: ITRI), which is transforming the way utilities and cities manage energy and water, announced that it has been named a Visionary in the 2022 Gartner Magic Quadrant for Managed IoT Connectivity Services, Worldwide1.
  • According to Gartner, the Managed IoT connectivity service market enables connectivity, data collection, and analysis and additional decision services that are necessary for connected solutions.
  • We are proud to be named a Visionary by Gartner.
  • 1 Gartner, Magic Quadrant for Managed IoT Connectivity Services, Worldwide, Pablo Arriandiaga, Eric Goodness, Leif-Olof Wallin, Kameron Chao, 31 January 2022
    Gartner and Magic Quadrant are registered trademarks of Gartner, Inc. and/or its affiliates in the U.S. and internationally and is used herein with permission.